Patent ID: 9724336
Date: 2017-08-08
CPC Classifications: A61K,A61P,C07D

Claim:
1. A method for treating hypertriglyceridemia, hypertriglyceridemia-associated atherosclerosis or hypertriglyceridemia-associated pancreatitis in a patient, which comprises administering a therapeutically effective amount of a compound of Formula 1 or its pharmaceutically acceptable salt in combination with a therapeutically effective amount of olmesartan medoxomil or its pharmaceutically acceptable salt to the patient in need thereof, wherein the combination is synergistic in treating the hypertriglyceridemia, hypertriglyceridemia-associated atherosclerosis or hypertriglyceridemia-associated pancreatitis, and the compound of Formula 1 or its pharmaceutically acceptable salt is administered in a dose of 20 mg/kg/day and the olmesartan medoxomil or its pharmaceutically acceptable salt is administered in a dose of 3 mg/kg/day: